Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 5:36 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 121–144 of 1,480 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Commercially Available Clear all

Conditions: Renal Transplantation
Interventions: Belatacept; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years and older
U.S. locations: 7
States / cities: La Jolla, California • Atlanta, Georgia • New Iberia, Louisiana + 4 more

Conditions: Gastrointestinal Dysfunction, Physiological Stress, Cognition - Other
Interventions: Yogurt with B. lactis and added honey, Yogurt with heat-inactivated B. lactis and added cane sugar; Dietary Supplement
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 22 Years to 64 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Postoperative Recovery, Total Knee Arthroplasty
Interventions: Xcelerated Recovery Nutritional Supplement; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 65 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Diet Modification
Interventions: Low fiber, Placebo, High fiber; Dietary Supplement
Lead sponsor: University of Minnesota; Other
Eligibility: 20 Years to 49 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Diabetes Mellitus, Type 2
Interventions: Semaglutide, Standard of care; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 1,278 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 180
States / cities: Buena Park, California • Burbank, California • Costa Mesa, California + 144 more

Conditions: Biliary Tract Neoplasms, Neoplasms, Gastrointestinal Diseases, Digestive System Diseases, Biliary Tract, Stents
Interventions: Evolution® Biliary Stent - Uncovered; Device
Lead sponsor: Cook Group Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 113 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 8
States / cities: Mobile, Alabama • Boca Raton, Florida • Jacksonville, Florida + 5 more

Conditions: Lung Cancer
Interventions: Ability to order FirstLook™, Continuing Medical Education for Lung Cancer; Diagnostic Test · Other
Lead sponsor: Delfi Diagnostics Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 3
States / cities: Aurora, Colorado • Jacksonville, Florida • Durham, North Carolina

Conditions: Diabetes Mellitus, Type 2
Interventions: semaglutide, oral glucose-lowering medications (commercially available); Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years and older
Enrollment: 1,018 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 25
States / cities: Alhambra, California • Costa Mesa, California • La Jolla, California + 20 more

Conditions: Resting Metabolic Rate, Appetite, Heart Rate Variability
Interventions: Normobaric Hypoxia, Normobaric Normoxia; Device
Lead sponsor: Florida State University; Other
Eligibility: 20 Years to 45 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Aortic Stenosis
Interventions: Medtronic TAV, Edwards TAV; Device
Lead sponsor: Medtronic Cardiovascular; Industry
Eligibility: 18 Years to 105 Years
Enrollment: 225 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 71
States / cities: Birmingham, Alabama • Phoenix, Arizona • Tucson, Arizona + 58 more

Conditions: Liver Neoplasms
Interventions: SonoVue-enhanced ultrasound, Unenhanced ultrasound; Drug · Other
Lead sponsor: Bracco Diagnostics, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 349 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Princeton, New Jersey

Conditions: Aortic Aneurysm, Abdominal
Interventions: IMPEDE-FX RapidFill Implants, EndoVascular Aneurysm Repair; Device · Procedure
Lead sponsor: Shape Memory Medical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2031
U.S. locations: 39
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Los Angeles, California + 32 more

Conditions: Osteo Arthritis Knee, Knee Arthritis, Monitoring Orthopedic Devices, Total Knee Arthroplasty, Total Knee Replacement
Interventions: Persona IQ; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 4
States / cities: Granger, Indiana • St Louis, Missouri • Charlotte, North Carolina + 1 more

Conditions: Traumatic Brain Injury
Interventions: Xbox One Kinect Gaming; Other
Lead sponsor: Washington D.C. Veterans Affairs Medical Center; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Hemophilia
Interventions: Fitusiran; Drug
Lead sponsor: Genzyme, a Sanofi Company; Industry
Eligibility: 12 Years and older · Male only
Enrollment: 281 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 10
States / cities: Phoenix, Arizona • Los Angeles, California • Orange, California + 7 more

Conditions: Meningococcal Meningitis
Interventions: MenACWY-CRM conjugate vaccine, Licensed comparator; Biological
Lead sponsor: Novartis Vaccines; Industry
Eligibility: 11 Years to 18 Years
Enrollment: 389 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 32
States / cities: Birmingham, Alabama • Fremont, California • Fresno, California + 21 more

Conditions: Pre-Frail Older Adults
Interventions: Pharyngeal Swallowing Exercises, Protein Supplementation, MRI; Behavioral · Dietary Supplement · Device
Lead sponsor: NYU Langone Health; Other
Eligibility: 65 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 2
States / cities: New York, New York

Conditions: Stress Disorders, Post-Traumatic
Interventions: Transcranial Magnetic Stimulation, Robotic Arm; Device
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 70 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: San Antoio, Texas

Conditions: Patient Positioning, Monitoring, Physiologic, Pressure Ulcer
Interventions: Zephyr BioPatch; Device
Lead sponsor: Medtronic - MITG; Industry
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Transtibial Amputation - Unilateral
Interventions: Fiberglass Composite foot, Carbon Fiber Composite Foot; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 21 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Frail Older Adults
Interventions: CogXergaming, Matter of Balance Training; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 60 Years and older
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Rehumanization Intervention, Control Intervention
Interventions: Rehumanized Intervention, Control Intervention, Clinical Interview, Self-Report Measures, Blood Draw; Other · Diagnostic Test
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 40 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Heart Failure With Preserved Ejection Fraction (HFPEF), Heart Failure With Normal Ejection Fraction, Heart Failure, Diastolic
Interventions: Exogenous Ketone Drink, Placebo; Dietary Supplement
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Corneal Staining
Interventions: Opti-Free RepleniSH, ReNu MultiPlus, Balafilcon A, Unisol 4; Device · Other
Lead sponsor: Alcon Research; Industry
Eligibility: 18 Years to 35 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010
U.S. locations: 1
States / cities: Fort Worth, Texas

Search by objective public record fields.

A Belatacept Compassionate Use Study for Patients With a Kidney Transplant

NECTAR Study: Nectar (Honey) Effects on Comfort, Thoughts, and Regularity

Nutrition and Swelling

Sunfiber and the Microbiota

Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial

Evolution® Biliary Stent System Clinical Study

Implementing Fragmentomics Into Real World Screening IntervenTions to Evaluate Clinical Utility Among Individuals With Elevated Risk for Lung Cancer

A Research Study Comparing RYBELSUS® to Other Blood Sugar Lowering Tablets in People Living in America With Type 2 Diabetes (REALYSE)

Effects of Overnight Low Oxygen Exposure on Energy Balance

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

SonoVue®-Enhanced Ultrasound Versus Unenhanced US for Focal Liver Lesion Characterization

AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion

Persona IQ Cohort Study

Using the Xbox Kinect for Chronic TBI

Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX

Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine

Pharyngeal Exercise (Plus Protein)

Accelerated Image-Guided Robotically Delivered Transcranial Magnetic Stimulation for Combat PTSD

An Assessment of the Zephyr BioPatch and Its Ability to Monitor Patient Position

Comparative Performance of Dynamic Elastic Response Feet

CogXergaming to Promote Physical Activity and Cognitive Function in Frail Older Adults

Reducing Self-Dehumanization to Examine Oxytocin and Suicide Risk

Chronic Exogenous Ketosis in HFpEF

Assessment of Tear Film-Based Proteins Associated With Care Solution Induced Corneal Staining